Delivery Order SPE2DB22D1017-SPE2DB25FYSCG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $1,181.68 under a firm fixed-price contract. This award represents a non-set-aside, competitively awarded delivery order with a completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-procured delivery order by the Defense Logistics Agency on July 10, 2025, for Nucynta ER 100 mg tablets (60 count). The order, valued at $2,944.08 with a firm fixed price structure, is scheduled for completion by July 11, 2025, and will be performed at the company's Conshohocken facility. This award carries no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count) with a ceiling value of $1,400.62. This competitive, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $4,749.30. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $3,614.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nucynta ER 100 mg tablets (60-count bottles). This is a non-set-aside contract with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSCGDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills DLA medical supply requirements across a broad spectrum of therapeutic areas. The company's extensive federal contract portfolio demonstrates its capacity to supply brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. Through the DLA Troop Support Medical prime contract, AmerisourceBergen is positioned to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this specific delivery order representing a routine pharmaceutical supply transaction within that larger contractual framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/26/25 |